These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7915889)

  • 21. Managing HIV. Part 3. Mechanisms of disease. 3.2 How HIV produces immune deficiency.
    Ffrench R; Stewart GJ; Penny R; Levy JA
    Med J Aust; 1996 Feb; 164(3):166-71. PubMed ID: 8628137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
    Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
    J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat.
    Poznansky MC; Foxall R; Mhashilkar A; Coker R; Jones S; Ramstedt U; Marasco W
    Hum Gene Ther; 1998 Mar; 9(4):487-96. PubMed ID: 9525310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The natural history of HIV infection: implications for the assessment of antiretroviral therapy.
    Corey L; Coombs RW
    Clin Infect Dis; 1993 Feb; 16 Suppl 1():S2-6. PubMed ID: 8093843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vgamma9Vdelta2 T cells in chronically infected patients undergoing structured treatment interruption.
    Martini F; Poccia F; Goletti D; Carrara S; Vincenti D; D'Offizi G; Agrati C; Ippolito G; Colizzi V; Pucillo LP; Montesano C
    J Infect Dis; 2002 Sep; 186(6):847-50. PubMed ID: 12198622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short communication: HIV antigen-specific reactivation of HIV infection from cellular reservoirs: implications in the settings of therapeutic vaccinations.
    Shete A; Thakar M; Singh DP; Gangakhedkar R; Gaikwad A; Pawar J; Paranjape R
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):835-43. PubMed ID: 21936714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Virus-induced immune deficiency disease AIDS: direct pathogenic effect of the virus or immunopathology?].
    Zinkernagel R
    Verh Dtsch Ges Pathol; 1994; 78():166-70. PubMed ID: 7533980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward an understanding of the correlates of protective immunity to HIV infection.
    Haynes BF; Pantaleo G; Fauci AS
    Science; 1996 Jan; 271(5247):324-8. PubMed ID: 8553066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular virology and immunology of HIV infection.
    Chinen J; Shearer WT
    J Allergy Clin Immunol; 2002 Aug; 110(2):189-98. PubMed ID: 12170257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does HIV cause depletion of CD4+ T cells in vivo by the induction of apoptosis?
    Jaworowski A; Crowe SM
    Immunol Cell Biol; 1999 Feb; 77(1):90-8. PubMed ID: 10101690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause?
    Grossman Z; Meier-Schellersheim M; Sousa AE; Victorino RM; Paul WE
    Nat Med; 2002 Apr; 8(4):319-23. PubMed ID: 11927927
    [No Abstract]   [Full Text] [Related]  

  • 32. The immunopathology of HIV infection.
    Andrews CA; Koup RA
    J Antimicrob Chemother; 1996 May; 37 Suppl B():13-25. PubMed ID: 8818826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD8 T-cell-mediated inhibition of HIV replication in HIV infected adults and children.
    Plaeger-Marshall S; Hausner MA; Isacescu V; Giorgi JV
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1375-6. PubMed ID: 1281656
    [No Abstract]   [Full Text] [Related]  

  • 34. Failure to control growth of mycobacteria in blood from children infected with human immunodeficiency virus and its relationship to T cell function.
    Tena GN; Young DB; Eley B; Henderson H; Nicol MP; Levin M; Kampmann B
    J Infect Dis; 2003 May; 187(10):1544-51. PubMed ID: 12721934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo analysis of Nef's role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss.
    Watkins RL; Foster JL; Garcia JV
    Retrovirology; 2015 Jul; 12():61. PubMed ID: 26169178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic indices for the course of HIV infection].
    Hess G
    Verh Dtsch Ges Inn Med; 1991; 97():386-90. PubMed ID: 1687300
    [No Abstract]   [Full Text] [Related]  

  • 37. New perspectives on HIV pathogenesis. Viral replication is continuous throughout the course of disease.
    J Assoc Nurses AIDS Care; 1995; 6(5):26-7. PubMed ID: 8785413
    [No Abstract]   [Full Text] [Related]  

  • 38. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
    Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing concepts in HIV infection: challenges for the 1990s.
    Levy JA
    AIDS; 1990 Nov; 4(11):1051-8. PubMed ID: 1980820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.